Events

« All Events

ISCT 2025

May 7 - May 10

ISCT is the global leader focused on pre-clinical and translational aspects of developing cell and gene-based therapeutics, thereby advancing scientific research into innovative treatments for patients.

Add to calendar

• Google Calendar
• iCalendar
• Outlook 365
• Outlook Live

Details

Start:

May 7

End:

May 10

Event Category:

Conference

Website:

https://www.isctglobal.org/annual-meeting/homepage

Venue

Ernest N. Morial Convention Center

New Orleans, LA United States

Related Events

• 

  World Vaccine Congress

  April 22 - April 24
• 

  ASGCT 2025

  May 13 - May 17
• 

  Pharma Manufacturing World Summit

  May 20 - May 22

News

• GHO & Ampersand Complete Acquisition of Avid Bioservices

  February 5, 2025

  Download PDF Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners Acquisition of biologics Contract Development and Manufacturing Organisation Avid Bioservices now completed GHO […]

  Read more

• Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger

  February 5, 2025

  Download PDFAvid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger TUSTIN, Calif., February 5, 2025 — Avid […]

  Read more

• Avid Stockholders Approve Transaction with GHO and Ampersand

  January 30, 2025

  Download PDFTUSTIN, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve […]

  Read more

• Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction

  November 6, 2024

  Download PDFTUSTIN, Calif. and LONDON and BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing […]

  Read more

• Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

  September 12, 2024

  Download PDFTUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and […]

  Read more

• Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance

  May 23, 2024

  Download PDFTUSTIN, Calif., May 23, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and […]

  Read more

< View Older News